RAM
MRNA icon

Riggs Asset Management’s Moderna MRNA Stock Holding History

Riggs Asset Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-16
Closed -$442 – 570
2025
Q2 		$442 Buy
+16
New +$421 ﹤0.01% 853
2024
Q3 		– Sell
-3
Closed -$357 – 672
2024
Q2 		$357 Buy
+3
New +$380 ﹤0.01% 582
2023
Q2 		– Sell
-100
Closed -$15.4K – 401
2023
Q1 		$15.4K Hold
100
– – 0.01% 201
2022
Q4 		$18K Hold
100
– – 0.01% 174
2022
Q3 		$12K Buy
+100
New +$15.2K ﹤0.01% 207
2021
Q4 		– Sell
-13
Closed -$5K – 328
2021
Q3 		$5K Buy
+13
New +$4.79K ﹤0.01% 264

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Riggs Asset Management's MRNA Position: Q3 2025 in Review

Riggs Asset Management sold out of Moderna (MRNA) in Q3 2025, closing a stake of 16 shares — an estimated $442 sold.

Riggs Asset Management first reported a position in MRNA in Q3 2021 and held it in 6 quarters. The position peaked at $18K in Q4 2022. 643 funds tracked by Wall St. Rank hold MRNA as of Q3 2025.

  • Riggs Asset Management reported no remaining Moderna position as of Q3 2025 after selling out during the quarter.
  • Riggs Asset Management sold 16 Moderna shares in Q3 2025, an estimated $442.
  • Riggs Asset Management first reported a position in Moderna in Q3 2021 and held it in 6 quarters.
  • Riggs Asset Management's Moderna position peaked at $18K in Q4 2022.
  • 643 funds tracked by Wall St. Rank held Moderna as of Q3 2025.

Based on Riggs Asset Management's 13F filing for Q3 2025, filed 13 Nov 2025.